Beyond inflammation, omega-3s support cardiovascular health, brain function, and joint mobility
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease
the present invention also relates to a pharmaceutical or diagnostic composition according to the above, which in addition to one or more of the BPC peptide salts of the present invention, contains trehalose, in particular for peroral use, and/or pharmaceutically or diagnostically acceptable carriers, dilutents and/or additives
PCD patients treated with L-carnitine in the Faroe Islands are thus not offered primary prevention with an ICD, instead they are, apart from being treated with L-carnitine, also closely monitored in an outpatient setting with regular blood tests and consultations with a clinical geneticist and cardiologist
Its presence indicates more rigorous quality control
PMID: 8 DixonSJLembergKMLamprechtMRSkoutaRZaitsevEMGleasonCEet al
